ResMed Inc (RMD)
216.16
-0.78
(-0.36%)
USD |
NYSE |
May 07, 16:00
215.05
-1.11
(-0.51%)
After-Hours: 20:00
ResMed Revenue (TTM): 4.584B for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.584B |
| December 31, 2023 | 4.504B |
| September 30, 2023 | 4.375B |
| June 30, 2023 | 4.223B |
| March 31, 2023 | 4.016B |
| December 31, 2022 | 3.763B |
| September 30, 2022 | 3.624B |
| June 30, 2022 | 3.578B |
| March 31, 2022 | 3.539B |
| December 31, 2021 | 3.444B |
| September 30, 2021 | 3.349B |
| June 30, 2021 | 3.197B |
| March 31, 2021 | 3.091B |
| December 31, 2020 | 3.092B |
| September 30, 2020 | 3.028B |
| June 30, 2020 | 2.957B |
| March 31, 2020 | 2.892B |
| December 31, 2019 | 2.784B |
| September 30, 2019 | 2.699B |
| June 30, 2019 | 2.607B |
| March 31, 2019 | 2.525B |
| December 31, 2018 | 2.455B |
| September 30, 2018 | 2.405B |
| June 30, 2018 | 2.340B |
| March 31, 2018 | 2.273B |
| Date | Value |
|---|---|
| December 31, 2017 | 2.196B |
| September 30, 2017 | 2.125B |
| June 30, 2017 | 2.067B |
| March 31, 2017 | 2.029B |
| December 31, 2016 | 1.968B |
| September 30, 2016 | 1.893B |
| June 30, 2016 | 1.839B |
| March 31, 2016 | 1.773B |
| December 31, 2015 | 1.742B |
| September 30, 2015 | 1.710B |
| June 30, 2015 | 1.679B |
| March 31, 2015 | 1.641B |
| December 31, 2014 | 1.616B |
| September 30, 2014 | 1.578B |
| June 30, 2014 | 1.555B |
| March 31, 2014 | 1.554B |
| December 31, 2013 | 1.540B |
| September 30, 2013 | 1.532B |
| June 30, 2013 | 1.514B |
| March 31, 2013 | 1.472B |
| December 31, 2012 | 1.437B |
| September 30, 2012 | 1.393B |
| June 30, 2012 | 1.369B |
| March 31, 2012 | 1.338B |
| December 31, 2011 | 1.303B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.607B
Minimum
Jun 2019
4.584B
Maximum
Mar 2024
3.467B
Average
3.396B
Median
Revenue (TTM) Benchmarks
| Boston Scientific Corp | 14.71B |
| Align Technology Inc | 3.917B |
| Stryker Corp | 20.96B |
| Integer Holdings Corp | 1.633B |
| Insulet Corp | 1.697B |